shutterstock_243410305_ir_stone

IR Stone / Shutterstock.com

25 November 2019Big PharmaInternational Quality & Productivity Center

Event preview: The election, Brexit, and the UPC

What is the ‘Brexit conundrum’ as regards the UK patent landscape?

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Gilead scores win in fake HIV drug dispute

Polsinelli grows roster with ex-corporate counsel

Dexcom suffers second patent revocation at hands of UPC

Sanofi signs global rights deal to develop rare cancer therapy

WBD to merge with firm to create ‘powerhouse’ practice

Novo Nordisk files fresh lawsuits to intercept Wegovy generics

UPC delivers first 'imminent infringement' decision in biosimilar dispute

AstraZeneca unit draws line under Samsung dispute